미국의 임상시험용 포장 시장 규모, 점유율, 동향 분석 보고서 : 소재별, 제품별, 최종 용도별, 부문 예측, 주요 기업, 경쟁 분석(2025-2030년)

U.S. Clinical Trial Packaging Market Summary

The U.S. clinical trial packaging market size was estimated at USD 915.9 million in 2024 and is projected to reach USD 1,611.4 million by 2030, growing at a CAGR of 9.9% from 2025 to 2030. The growth is driven by the increasing number of clinical trials, particularly for novel drugs and therapies, including biologics and gene therapies.

The rising prevalence of chronic diseases necessitates continuous research and development in the pharmaceutical and biotechnology sectors, leading to a higher demand for specialized packaging solutions to ensure drug stability, safety, and integrity throughout the trial phases. Increasing regulatory scrutiny and the complexity of trial protocols necessitate secure and adaptive packaging formats. The growth of the U.S. clinical trial packaging industry is primarily driven by the rising number of clinical trials, spurred by growing investments in pharmaceutical R&D and the surge in novel drug development.

Innovation is a cornerstone of the U.S. clinical trial packaging industry, continuously driven by the need for enhanced drug stability, patient compliance, and supply chain efficiency. Companies invest in smart packaging technologies, such as RFID and temperature monitoring devices, to provide real-time data on product conditions and ensure integrity throughout cold chain logistics.

U.S. Clinical Trial Packaging Market Report Segmentation

This report forecasts revenue growth at U.S. level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. clinical trial packaging industry report based on material, product, and end use:

• By Material Outlook (Revenue, USD Million, 2018 - 2030)
• Plastic
• Glass
• Metal
• Paper & Corrugated Fiber
• By Product Outlook (Revenue, USD Million, 2018 - 2030)
• Syringes
• Vials & Ampoules
• Bottles
• Bags & Pouches
• Others
• By End Use Outlook (Revenue, USD Million, 2018 - 2030)
• Research Laboratories
• Clinical Research Organizations
• Drug Manufacturing Facilities

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Raw Materials & Third-Party Perspectives
  • 1.3.4. Primary Research
• 1.4. Information Analysis
  • 1.4.1. Data Analysis Models
• 1.5. Market Formulation & Data Visualization
• 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Clinical Trial Packaging Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related Market Outlook
• 3.2. Industry Value Chain Analysis
• 3.3. Regulatory Framework
• 3.4. Market Dynamics
  • 3.4.1. Market Driver Analysis
  • 3.4.2. Market Restraint Analysis
  • 3.4.3. Industry Challenges
  • 3.4.4. Industry Opportunities
• 3.5. Industry Analysis Tools
  • 3.5.1. Porter's Five Forces Analysis
  • 3.5.2. Macro-environmental Analysis

Chapter 4. U.S. Clinical Trial Packaging Market: Material Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Clinical Trial Packaging Market: Material Movement Analysis & Market Share, 2024 & 2030
• 4.3. Plastic
  • 4.3.1. Plastic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Glass
  • 4.4.1. Glass Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Metal
  • 4.5.1. Metal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Paper & Corrugated Fiber
  • 4.6.1. Paper & Corrugated Fiber Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Clinical Trial Packaging Market: Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Clinical Trial Packaging Market: Product Movement Analysis & Market Share, 2024 & 2030
• 5.3. Syringes
  • 5.3.1. Syringes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Vials & Ampoules
  • 5.4.1. Vials & Ampoules Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Bottles
  • 5.5.1. Bottles Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Bags & Pouches
  • 5.6.1. Bags & Pouches Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Clinical Trial Packaging Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. U.S. Clinical Trial Packaging Market: End Use Movement Analysis & Market Share, 2024 & 2030
• 6.3. Research Laboratories
  • 6.3.1. Research Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Clinical Research Organizations
  • 6.4.1. Clinical Research Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Drug Manufacturing Facilities
  • 6.5.1. Drug Manufacturing Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. U.S. Clinical Trial Packaging Market - Competitive Landscape

• 7.1. Recent Developments & Impact Analysis, By Key Market Participants
• 7.2. Company Categorization
• 7.3. Company Heat Map
• 7.4. Position Analysis, 2024
• 7.5. Strategy Mapping
  • 7.5.1. Expansion
  • 7.5.2. Mergers & Acquisition
  • 7.5.3. Partnerships & Collaborations
  • 7.5.4. New Film Type Launches
  • 7.5.5. Research And Development
• 7.6. Company Profiles
  • 7.6.1. Catalent, Inc.
    • 7.6.1.1. Participant's overview
    • 7.6.1.2. Financial performance
    • 7.6.1.3. Product benchmarking
    • 7.6.1.4. Recent developments
  • 7.6.2. PCI Pharma Services
    • 7.6.2.1. Participant's overview
    • 7.6.2.2. Financial performance
    • 7.6.2.3. Product benchmarking
    • 7.6.2.4. Recent developments
  • 7.6.3. Parexel International (MA) Corporation
    • 7.6.3.1. Participant's overview
    • 7.6.3.2. Financial performance
    • 7.6.3.3. Product benchmarking
    • 7.6.3.4. Recent developments
  • 7.6.4. Piramal Pharma Limited
    • 7.6.4.1. Participant's overview
    • 7.6.4.2. Financial performance
    • 7.6.4.3. Product benchmarking
    • 7.6.4.4. Recent developments
  • 7.6.5. Rubicon Research Limited
    • 7.6.5.1. Participant's overview
    • 7.6.5.2. Financial performance
    • 7.6.5.3. Product benchmarking
    • 7.6.5.4. Recent developments
  • 7.6.6. Schreiner Group
    • 7.6.6.1. Participant's overview
    • 7.6.6.2. Financial performance
    • 7.6.6.3. Product benchmarking
    • 7.6.6.4. Recent developments
  • 7.6.7. Sharp Services, LLC
    • 7.6.7.1. Participant's overview
    • 7.6.7.2. Financial performance
    • 7.6.7.3. Product benchmarking
    • 7.6.7.4. Recent developments